hVIVO (HVO) Competitors GBX 22.95 +0.85 (+3.85%) (As of 11:45 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlines HVO vs. SLN, OXB, PRTC, HZD, VRP, BVXP, ARIX, 4BB, AVCT, and FARNShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), Arix Bioscience (ARIX), 4basebio (4BB), Avacta Group (AVCT), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "biotechnology" industry. hVIVO vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix Arix Bioscience 4basebio Avacta Group Faron Pharmaceuticals Oy Silence Therapeutics (LON:SLN) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, community ranking, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment. Does the media favor SLN or HVO? In the previous week, Silence Therapeutics had 1 more articles in the media than hVIVO. MarketBeat recorded 3 mentions for Silence Therapeutics and 2 mentions for hVIVO. Silence Therapeutics' average media sentiment score of 0.67 beat hVIVO's score of 0.37 indicating that Silence Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Silence Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive hVIVO 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals believe in SLN or HVO? 34.9% of hVIVO shares are held by institutional investors. 14.0% of hVIVO shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community favor SLN or HVO? Silence Therapeutics received 80 more outperform votes than hVIVO when rated by MarketBeat users. However, 69.89% of users gave hVIVO an outperform vote while only 68.81% of users gave Silence Therapeutics an outperform vote. CompanyUnderperformOutperformSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% hVIVOOutperform Votes12369.89% Underperform Votes5330.11% Which has better earnings and valuation, SLN or HVO? hVIVO has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M42.34N/A-£48.60-11.01hVIVO£67.21M2.33£17.45M£0.03766.67 Is SLN or HVO more profitable? hVIVO has a net margin of 25.96% compared to Silence Therapeutics' net margin of 0.00%. hVIVO's return on equity of 58.04% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A hVIVO 25.96%58.04%11.97% SummaryhVIVO beats Silence Therapeutics on 9 of the 13 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£156.49M£164.71M£5.05B£1.38BDividend Yield0.73%3.25%4.97%11.73%P/E Ratio766.67329.4797.341,551.35Price / Sales2.3314,857.981,218.42209,189.85Price / Cash4.9411.6733.5132.93Price / Book3.837.115.802.80Net Income£17.45M-£18.52M£119.07M£152.70M7 Day Performance-13.94%-0.25%-1.83%-0.54%1 Month Performance-18.87%8.08%-3.64%7.07%1 Year Performance26.90%25.99%31.62%91.74% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVON/AGBX 22.95+3.8%N/AN/A£156.15M£67.21M765.00N/ANews CoverageSLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100High Trading VolumeOXBOxford Biomedica0.9962 of 5 starsGBX 412.50flatGBX 433.33+5.1%+113.7%£434.61M£97.28M-287.15891Gap DownHigh Trading VolumePRTCPureTech HealthN/AGBX 162+0.1%N/A-5.6%£387.86M£3.33M-702.61300HZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,710-1.1%N/A-5.2%£193.66M£13.60M2,298.1612ARIXArix BioscienceN/AGBX 142flatN/A+29.1%£183.73M£14.16M1,290.9194BB4basebioN/AGBX 1,310+0.8%N/A+146.8%£167.81M£311,000.00-1,666.67101Insider TradeNews CoverageAVCTAvacta GroupN/AGBX 46.61+5.3%N/A-67.2%£167.00M£22.62M-532.33120News CoverageFARNFaron Pharmaceuticals OyN/AGBX 143.50-2.7%N/A-44.3%£150.13M£-725,000.00-462.5034 Related Companies and Tools Related Companies SLN Competitors OXB Competitors PRTC Competitors HZD Competitors VRP Competitors BVXP Competitors ARIX Competitors 4BB Competitors AVCT Competitors FARN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:HVO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HVO Stock Alerts